J 2022

Phenotypic spectrum of the SCN1A mutation (from febrile seizures to Dravet syndrome)

ČESKÁ, Katarína, Pavlína DANHOFER, Ondřej HORÁK, Klára ŠPANĚLOVÁ, Senad KOLÁŘ et. al.

Basic information

Original name

Phenotypic spectrum of the SCN1A mutation (from febrile seizures to Dravet syndrome)

Authors

ČESKÁ, Katarína (703 Slovakia, belonging to the institution), Pavlína DANHOFER (203 Czech Republic, belonging to the institution), Ondřej HORÁK (203 Czech Republic, belonging to the institution), Klára ŠPANĚLOVÁ (203 Czech Republic, belonging to the institution), Senad KOLÁŘ (203 Czech Republic, belonging to the institution), Hana OŠLEJŠKOVÁ (203 Czech Republic, belonging to the institution) and Štefánia AULICKÁ (703 Slovakia, belonging to the institution)

Edition

Bratislava Medical Journal - Bratislavské lekárske listy, BRATISLAVA, Univerzita Komenského, 2022, 0006-9248

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

Slovakia

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.500

RIV identification code

RIV/00216224:14110/22:00128262

Organization unit

Faculty of Medicine

UT WoS

000812277000004

Keywords in English

Dravet's syndrome; sodium channel; functional analysis; prognosis

Tags

International impact, Reviewed
Změněno: 2/2/2023 13:48, Mgr. Tereza Miškechová

Abstract

V originále

Dravet's syndrome previously known as severe myoclonic epilepsy in infancy, is classified as epilepsy on a genetic basis (1). 70???80 % of the patients with the Dravet???s syndrome phenotype are associated with the detection of a sequence variant in the SCN1A gene (alpha 1 subunit of the voltage-gated sodium channel) (2). However, sequence variants in the SCN1A gene are associated with a very broad clinical spectrum, from asymptomatic carriers to the severe myoclonic epilepsy phenotype with severe disease (3). In the presented work, we retrospectively evaluated a group of 6 patients of the Department of Pediatric Neurology of the Medical Faculty of Masaryk University and the University Hospital in Brno with a proven missense mutation. Based on the specific pathogenic sequence variant, we correlated the patient???s phenotype with the location of the sequence variant in the SCN1A gene. The aim of the analysis was to verify the extent, to which the storage of a pathogenic sequence variant in the SCN1A gene corresponds to the clinical picture of the patient (Tab. 2, Fig. 2, Ref. 10). Text in PDF www.elis.sk